REFERENCES
- Kahana E, Alter M, Feldman S. Optic neuritis in relation to multiple sclerosis. J Neurol 1976; 2: 87–95
- Kuroiwa Y, Igata A, Itahara K, Tsubaki T. Nationwide survey of multiple sclerosis in Japan: Clinical analysis of 1084 cases. Neurology 1975; 25: 845–851
- Shibasaki H, McDonald W I, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981; 49: 253–271
- Yu Y L, Woo E, Hawkins B R, Ho H C, Huang C Y. Multiple sclerosis amongst Chinese in Hong Kong. Brain 1989; 112: 1445–1467
- Chang K H, Lyu R K, Chen C M, Hsu W C, Wu Y R, Chen S T, Ro L S. Clinical characteristics of multiple sclerosis in Twaiwan: a cross-sectional study. Multiple sclerosis 2006; 12: 501–506
- Singhal B S. Clinical profile and HLA-studies in Indian multiple sclerosis patients from the Bombay region. Multiple sclerosis East and West, Y Kuroiwa, L T Kurland. Kyushu University Press, Fukuoka 1982; 123–134
- Tan C T. Multiple sclerosis in Malaysia. Arch Neurol 1988; 45: 624–627
- Kuroiwa Y, Shibasaki H, Ikeda M. Prevalence of multiple sclerosis and its north-to-south gradient in Japan. Neuroepidemiology 1983; 2: 62–69
- Nakashima I, Fujihara K, Okita N, Takase S, Itoyama Y. Clinical and MRI study of brain stem and cerebellar involvement in Japanese patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1999; 67: 153–157
- Tsuda H, Ishikawa H, Matsunaga H, Mizutani T. A neuro-ophthalmological analysis in 80 cases of multiple sclerosis. Rinsho Shinkeigaku 2004; 44: 513–521
- McDonald W I, Compston A, Edan G, Goodkin D, Hartung H P, Lublin F D, McFarland H F, Paty D W, Polman C H, Reingold S C, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker B Y, Wolinsky J S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 12–127
- Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita K, Kawano Y, Hasuo K, Tobimatsu S, Kobayashi T. Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569–574
- Nakashima I, Fujihara K, Itoyama Y. Oligoclonal IgG bands in Japanese multiple sclerosis patients. J Neuroimmunol 1999; 101: 205–206
- Fukazawa T, Tashiro K, Hamada T, Moriwaka F, Matsumoto A, Shima K, Maruo Y. Multiple slcerosis in Hokkaido, the northernmost island of Japan: Prospective analysis of clinical feature. Intern Med 1992; 31: 349–352
- Optic Neuritis Study Group. The clinical profile of optic neuritis: Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991; 109: 1673–1678
- Isayama Y, Takahashi T, Shimoyoma T, Yamadori A. Acute optic neuritis and multiple slcerosis. Neurology 1982; 32: 73–76
- Beck R W, Gal R L, Bhatti M T. Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. Am J Ophthalmol 2004; 137: 77–83
- Jacobs D A, Galetta S L. Multiple sclerosis and the visual system. Ophthalmol Clin North Am 2004; 17: 265–273
- Chen L, Gorden L K. Ocular manifestations of multiple sclerosis. Curr opin in Ophthalmol 2005; 16: 315–320
- Rizzo J F, III, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988; 38: 185–190
- Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtas S, Platz P, Ryder L P. A long term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990; 27: 386–393
- Nilsson P, Larsson E M, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol 2005; 252: 396–402
- Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol 2005; 4: 341–348
- Johns K, Lavin P, Elliot J H, Partain C L. Magnetic resonance imaging of the brain in isolated optic neuritis. Arch Ophthalomol 1986; 104: 1486–1488
- Jacobs L, Munschauer F E, Kaba S E. Clinical and magnetic resonance imaging in optic neuritis. Neurology 1991; 41: 15–19
- Morrissey S P, Miller D H, Kendall B E, Kingsley D P, Kelly M A, Francis D A, MacManus D G, McDonald W I. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow up study. Brain 1993; 116: 135–146
- Wang J C, Tow S, Aung T, Lim S A, Cullen J F. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Experiment Ophthalmol 2001; 29: 312–315
- Lynn B H. Retrobulbar neuritis: a survey of the present condition of cases occurring over the last 56 years. Trans Ophthalmol Soc UK 1959; 79: 701–716
- Kurland L T, Beebe G W, Kurtzje J F, Nagler B M, Auth T L, Lessell S, Nefzger M D. Studies on the natural history of multiple sclerosis. 2. Progression from optic neuritis to multiple sclerosis. Acta Neurol Scand 1966; 42(Suppl 19)157
- Percy A K, Nobrega F T, Kurland L T. Optic neuritis and multiple sclerosis. Arch Ophthalmol 1972; 87: 135–139
- Hutchinson W M. Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry 1976; 39: 283–289
- Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 1983; 68: 371–377
- Anmarkrud N, Slettnes O N. Uncomplicated retrobulabr optic neuritis and the development of multiple sclrosis. Acta Ophthalmol 1989; 67: 306–309
- Rodriguez M, Siva A, Cross S A, O'Brien P C, Kurland L T. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995; 45: 244–250
- Filippini G, Comi G C, Cosi V, Bevilacqua L, Ferrarini M, Martilleni V, Bergamaschi R, Filippi M, Citterio A, D'Incerti L, et al. Sensitivities and predictive values of paraclinical tests for diagnosing multiple sclerosis. J Neurol 1994; 241: 132–137
- Optic neuritis study group. High- and low-risk profiles fro the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 2003; 121: 944–949
- Ivers R R, Goldstein N P. Multiple sclerosis: a current appraisal of symptoms and signs. Proc Mayo Clin 1963; 38: 457–466
- Rush J A, Younge B R. Paralysis of cranial nerves III, IV, and VI. Arch Ophthalmol 1981; 99: 76–79
- Keane J R. Bilateral sixth nerve palsy: analysis of 125 cases. Arch Ophthalmol 1976; 33: 681–683
- Miller N. Multiple sclerosis and related demyelinating diseases. Clinical Neuro-ophthalmology. Williams and Wilkins, Baltimore 1995; 4324
- Avitsky N, Rangell L. The ocular findings in multiple sclerosis. Proc Assoc Res Nerv Dis 1950; 28: 403–413
- Müri R M, Meienberg O. The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis. Arch Neurol 1985; 42: 851–855
- Kahana E, Leibowitz U, Alter M. Cerebral multiple sclerosis. Neurology 1971; 21: 1179–85
- Hawkins K, Behrens M. Homonymous hemianopia in multiple sclerosis: with report of bilateral cases. Br J Ophthalmol 1975; 59: 334–337
- Boldt H A, Haerer A F, Tourtellotte W W, Henserson J W, Dejong R M. Retrochiasmal visual field defects from multiple sclerosis. Arch Neurol 1963; 8: 565–575
- Keltner J L, Johnson C A, Spurr J O, Beck R W. Baseline visual field profile of optic neuritis. The experience of optic neuritis treatment trial. Arch Ophthalmol 1993; 111: 231–234